Glioblastoma | Treatment | Clinical trials

BRAINLIFE.ORG

	Topics
	Glioblastoma \| Treatment \| Clinical trials


	Home > Publications > Topics > Glioblastoma > Treatment > Clinical trials


	□ OVERVIEW

	CHEMOTHERAPY
	□ CARBOPLATIN
	□ LOMUSTINE
	□ METHOXYAMINE
	□ NEOADJUVANT CHEMOTHERAPY
	□ R-(-)-GOSSYPOL
	□ TAXANES	□ TEMOZOLOMIDE

	ELECTRIC AND MAGNETIC FIELDS
	□ TUMOR TREATING FIELDS

	IMMUNOTHERAPY
	□ BISPECIFIC ANTIBODY ARMED T CELLS
	□ CAR-T-CELLS	□ CELL THERAPY
	□ DENDRITIC CELLS
	□ IMMUNE CHECKPOINT INHIBITORS
	□ VACCINES
	□ VIRUSES

	INTEGRATIVE MEDICINE
	□ CIRCADIAN CLOCK

	NUCLEAR MEDICINE
	□ THERANOSTICS

	PHARMACOTHERAPY
	□ ARSENICALS	□ ANTIEPILEPTIC DRUGS
	□ DISULFIRAM
	□ IMMUNOSUPPRESSIVE DRUGS

	RADIOTHERAPY
	□ MARGINS
	□ PHOTODYNAMIC THERAPY	□ PROTON BEAM
	□ RADIOPHARMACEUTICALS	□ RADIOSENSITIZERS	□ RE-IRRADIATION

	SURGERY
	□ 5-AMINOLEVULINICACID
	□ BIOPSY
	□ EXTENT OF RESECTION
	□ FLAIRECTOMY
	□ RESECTION CAVITY

	TARGETED THERAPY
	□ AFATINIB	□ ANGIOGENES ISINHIBITORS	□ APTAMERS
	□ GLUTAMATE SIGNALING INHIBITORS
	□ IPILIMUMAB
	□ KINASE INHIBITORS
	□ LISAVANBULIN
	□ MICROENVIRONMENT MODULATORS
	□ NAVTEMADLIN	□ NIVOLUMAB
	□ OLAPARIB
	□ PEMBROLIZUMAB
	□ SACITUZUMAB GOVITECAN	□ SUNITINIB
	□ TISLELIZUMAB
	□ VELIPARIB